Scarica l'app Stockscreener
52.95
2.76%
1.4251
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$51.52
Aprire:
$52.03
Volume 24 ore:
389.87K
Relative Volume:
0.18
Capitalizzazione di mercato:
$8.24B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
56.32
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-0.51%
1M Prestazione:
-0.66%
6M Prestazione:
-15.74%
1 anno Prestazione:
-30.81%
Intervallo 1D:
$51.80
$53.23
Intervallo di 1 settimana:
$50.76
$53.75
Portata 52W:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
52.98 | 8.01B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.96 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.75 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.74 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
726.54 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.63 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Gains Recap: How does Bio Techne Corporation perform in inflationary periods2025 Pullback Review & Weekly Setup with High ROI Potential - خودرو بانک
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne - Benzinga
Here’s Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne’s (TECH) Long-Term Growth Profile - ca.finance.yahoo.com
Bio-Techne Faces Potential Pressure with Proposed Sales Notice - timothysykes.com
Royal Bank of Canada Cuts Stock Position in Bio-Techne Corp $TECH - MarketBeat
Plato Investment Management Ltd Invests $281,000 in Bio-Techne Corp $TECH - MarketBeat
6,799 Shares in Bio-Techne Corp $TECH Acquired by Petrus Trust Company LTA - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Fred Alger Management LLC - MarketBeat
Bio-Techne Corp Faces Uncertain Market with Planned Sale of Securities - StocksToTrade
The three-year earnings decline is not helping Bio-Techne's (NASDAQ:TECH share price, as stock falls another 5.8% in past week - Yahoo Finance
MBB Public Markets I LLC Purchases New Stake in Bio-Techne Corp $TECH - MarketBeat
Select Equity Group L.P. Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Amundi Lowers Position in Bio-Techne Corp $TECH - MarketBeat
Polar Asset Management Partners Inc. Decreases Position in Bio-Techne Corp $TECH - MarketBeat
NFJ Investment Group LLC Acquires New Position in Bio-Techne Corp $TECH - MarketBeat
Sandler Capital Management Takes $1.58 Million Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Curi RMB Capital LLC - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Bio-Techne Corp. Stock Slides 6.0%, Underperforms Peers - 富途牛牛
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Bio-Techne (TECH) Stock Is Down Today - Yahoo Finance
Bio-Techne at Morgan Stanley Conference: Strategic Insights on Growth and Challenges - Investing.com
CONMED appoints Bio-Techne CEO Kim Kelderman to board of directors - Investing.com
Bio-Techne CEO and Former Thermo Fisher Executive Kim Kelderman Joins CONMED's Board of Directors - Stock Titan
Bio-Techne at Baird Global Healthcare: Strategic Growth Amid Challenges - Investing.com
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - Ariva
Trexquant Investment LP Makes New $3.75 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
Applying big data sentiment scoring on Bio Techne CorporationWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Baird Financial Group Inc. Sells 91,254 Shares of Bio-Techne Corp $TECH - MarketBeat
Maverick Capital Ltd. Takes $30.66 Million Position in Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation a play on infrastructure spending2025 Key Lessons & Smart Money Movement Alerts - خودرو بانک
Can Bio Techne Corporation outperform in the next rallyWeekly Risk Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Bio-Techne upgraded to Outperform at RBC on strong growth potential - MSN
Market reaction to Bio Techne Corporation’s recent newsJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns By Investing.com - Investing.com Australia
Is it time to cut losses on Bio Techne CorporationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Pattern recognition hints at Bio Techne Corporation upside2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Understanding Bio Techne Corporation’s price movement2025 Investor Takeaways & Consistent Growth Stock Picks - Newser
Can Bio Techne Corporation benefit from deglobalizationWeekly Profit Summary & Stock Portfolio Risk Control - خودرو بانک
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns - Investing.com India
Iron Triangle Partners LP Acquires Shares of 250,000 Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Benzinga
Quantitative breakdown of Bio Techne Corporation recent move2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Candlestick signals on Bio Techne Corporation stock todayMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
Using portfolio simulators with Bio Techne Corporation includedWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Is Bio Techne Corporation a candidate for recovery playInsider Selling & Precise Buy Zone Tips - Newser
Is Bio Techne Corporation still worth holding after the dip2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Is Bio Techne Corporation stock a good dividend stock2025 Winners & Losers & Daily Stock Trend Watchlist - خودرو بانک
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
0.18%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):